To mimic the inflammatory conditions as seen in MS, we treated the ECs with the inflammatory cytokine TNF-α, thereby inducing the expression of adhesion molecules like ICAM-1 and VCAM-1 [30], resulting in enhanced monocyte adhesion to brain EC (Fig. 4b). Here, TNF is linked to myeloid sarcoma.